Cerinib

Cerinib uses and dosage

Cerinib (Ceritinib), generic Zykadia is a prescription medicine used to treat anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) for which patients who are unable to tolerate or have progressed on prior crizotinib therapy. Cerinib manufactured by Drug International Ltd. in Bangladesh. Ceritinib has to take 450 mg orally once daily with food. *First dose reduction: 300 mg qDay *Second dose reduction: 150 mg qDay *Unable to tolerate 150 mg/ day: Discontinue

Cerinib side effects

The most common adverse reactions of Ceritinib are: Diarrhea, nausea, vomiting, abdominal pain, loss of appetite, heartburn, constipation, or tiredness.

Originator brand

Zykadia by Novartis Pharmaceuticals

Made by

Drug International Pharma

This information is provided for reference only and is not medical advice. Always consult a qualified healthcare professional.